|
Tuning Mechanism‐Based Inactivators of Neuraminidases: Mechanistic and Structural Insights
|
journal
|
March 2014 |
|
Direct Affinity Purification and Supramolecular Organization of Human Lysosomal Cathepsin A
|
journal
|
August 1994 |
|
Cloning, Expression, and Chromosomal Mapping of a Human Ganglioside Sialidase
|
journal
|
July 1999 |
|
Cloning and Characterization of NEU2, a Human Gene Homologous to Rodent Soluble Sialidases
|
journal
|
April 1999 |
|
Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
|
journal
|
September 2020 |
|
Copurification and separation of β-galactosidase and sialidase from porcine testis
|
journal
|
January 1987 |
|
Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function
|
journal
|
August 1991 |
|
Identification and in Vitro Reconstitution of Lysosomal Neuraminidase from Human Placenta
|
journal
|
January 1989 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases
|
journal
|
September 1988 |
|
Protective protein in the bovine lysosomal β-galactosidase complex
|
journal
|
September 1997 |
|
Three-dimensional structure of the human protective protein: structure of the precursor form suggests a complex activation mechanism
|
journal
|
November 1995 |
|
The crystal structure of an intramolecular trans-sialidase with a NeuAcα2→3Gal specificity
|
journal
|
April 1998 |
|
Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis
|
journal
|
October 2013 |
|
Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1)
|
journal
|
January 2008 |
|
Human neuraminidases have reduced activity towards modified sialic acids on glycoproteins
|
journal
|
November 2020 |
|
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
|
Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice
|
journal
|
June 2018 |
|
Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept
|
journal
|
March 2021 |
|
AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
|
journal
|
December 2021 |
|
Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein
|
journal
|
June 2022 |
|
A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages
|
journal
|
April 2018 |
|
Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family
|
journal
|
March 2004 |
|
Short-term, high dose enzyme replacement therapy in sialidosis mice
|
journal
|
July 2005 |
|
Selective Inhibitors of Human Neuraminidase 1 (NEU1)
|
journal
|
November 2018 |
|
Kinetic and Structural Characterization of Sialidases (Kdnases) from Ascomycete Fungal Pathogens
|
journal
|
November 2021 |
|
Human Neuraminidase Isoenzymes Show Variable Activities for 9-O-Acetyl-sialoside Substrates
|
journal
|
January 2018 |
|
Trypanosoma cruzi Trans-sialidase Operates through a Covalent Sialyl−Enzyme Intermediate: Tyrosine Is the Catalytic Nucleophile
|
journal
|
May 2003 |
|
Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases
|
journal
|
April 2010 |
|
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
|
journal
|
May 1983 |
|
Preclinical Dose-Finding Study With a Liver-Tropic, Recombinant AAV-2/8 Vector in the Mouse Model of Galactosialidosis
|
journal
|
February 2012 |
|
Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis
|
journal
|
November 2013 |
|
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
|
journal
|
July 2015 |
|
Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis
|
journal
|
March 1997 |
|
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin β4
|
journal
|
January 2009 |
|
Highly accurate protein structure prediction with AlphaFold
|
journal
|
July 2021 |
|
Human Sialidase Neu3 is S-Acylated and Behaves Like an Integral Membrane Protein
|
journal
|
June 2017 |
|
New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability
|
journal
|
December 2016 |
|
Evidence for mitochondrial localization of a novel human sialidase (NEU4)
|
journal
|
August 2005 |
|
Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation
|
journal
|
March 1998 |
|
Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane
|
journal
|
June 2000 |
|
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.
|
journal
|
August 1982 |
|
Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.
|
journal
|
November 1993 |
|
Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter
|
journal
|
December 1998 |
|
Association of N-Acetylgalactosamine-6-sulfate Sulfatase with the Multienzyme Lysosomal Complex of β-Galactosidase, Cathepsin A, and Neuraminidase
|
journal
|
November 1996 |
|
Identification of a Sialidase Encoded in the Human Major Histocompatibility Complex
|
journal
|
February 1997 |
|
Lysosomal Neuraminidase: CATALYTIC ACTIVATION IN INSECT CELLS IS CONTROLLED BY THE PROTECTIVE PROTEIN/CATHEPSIN A
|
journal
|
September 2000 |
|
Intracellular Distribution of Lysosomal Sialidase Is Controlled by the Internalization Signal in Its Cytoplasmic Tail
|
journal
|
December 2001 |
|
Heterodimerization of the Sialidase NEU1 with the Chaperone Protective Protein/Cathepsin A Prevents Its Premature Oligomerization
|
journal
|
October 2009 |
|
The Aspergillus fumigatus Sialidase Is a 3-Deoxy-d-glycero-d-galacto-2-nonulosonic Acid Hydrolase (KDNase)
|
journal
|
March 2011 |
|
Proteolytic Activation of Human Cathepsin A
|
journal
|
April 2014 |
|
Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells
|
journal
|
August 2004 |
|
Crystal Structure of the Human Cytosolic Sialidase Neu2: EVIDENCE FOR THE DYNAMIC NATURE OF SUBSTRATE RECOGNITION
|
journal
|
October 2004 |
|
Lysosomal Sialidase (Neuraminidase-1) Is Targeted to the Cell Surface in a Multiprotein Complex That Facilitates Elastic Fiber Assembly
|
journal
|
February 2006 |
|
Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice
|
journal
|
September 2018 |
|
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency
|
journal
|
September 2020 |
|
Galactosialidosis: historic aspects and overview of investigated and emerging treatment options
|
journal
|
December 2016 |
|
Elastin-derived peptides potentiate atherosclerosis through the immune Neu1–PI3Kγ pathway
|
journal
|
December 2013 |
|
Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A
|
journal
|
March 1998 |
|
Structural basis of sialyltransferase activity in trypanosomal sialidases
|
journal
|
January 2000 |
|
Human sialidase NEU4 long and short are extrinsic proteins bound to outer mitochondrial membrane and the endoplasmic reticulum, respectively
|
journal
|
September 2009 |
|
Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis
|
journal
|
November 2000 |
|
Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage
|
journal
|
February 2008 |
|
The human gene mutation database
|
journal
|
January 1998 |
|
The carbohydrate-active enzyme database: functions and literature
|
journal
|
November 2021 |
|
Human Placental Sialidase: Further Purification and Characterization
|
journal
|
January 1988 |
|
Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis
|
journal
|
April 2004 |
|
Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.
|
journal
|
December 1996 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Towards automated crystallographic structure refinement with phenix.refine
|
journal
|
March 2012 |
|
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
|
journal
|
October 2019 |
|
A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model
|
journal
|
May 2010 |
|
Human placental neuraminidase
|
journal
|
June 1985 |
|
Purification and partial characterization of lysosomal neuraminidase from human placenta
|
journal
|
January 1987 |
|
Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll‐like Receptor 4
|
journal
|
May 2020 |
|
Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis
|
journal
|
November 2020 |
|
Regulated lysosomal exocytosis mediates cancer progression
|
journal
|
December 2015 |
|
Structure of the murine lysosomal multienzyme complex core
|
journal
|
May 2021 |
|
Desialylation of surface receptors as a new dimension in cell signaling
|
journal
|
July 2013 |
|
Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells
|
journal
|
April 2018 |
|
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages
|
journal
|
February 2021 |
|
Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway
|
journal
|
March 2020 |
|
Purification and Characterization of Sialidase from Porcine Liver.
|
journal
|
January 1998 |
|
Pathogenesis, emerging therapeutic targets and treatment in sialidosis
|
journal
|
April 2015 |
|
Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I
|
journal
|
March 2020 |
|
Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice
|
journal
|
January 2022 |
|
Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1
|
journal
|
September 2014 |